WASHINGTON (AP) - U.S. health officials have approved a new generic version of EpiPen, the emergency allergy medication.
The Food and Drug Administration's action Thursday opens the door to more competition for a drug that has faced public outrage over its price tag. The injections are stocked by schools and parents to treat allergic reactions to food and bug bites.
The new generic version will be sold by Teva Pharmaceuticals.
EpiPen maker Mylan has dominated the $1 billion market for two decades. Competing shots are not widely marketed or prescribed by doctors.
In 2016, Congress blasted Mylan for raising the price to $600, a five-fold increase over nearly a decade. The company responded by launching its own lower-cost generic version for $300.
- Generic EpiPen approved by health officials
- Reports of EpiPen shortage
- U.S. health officials approve ketamine-like drug for severe depression
- Illinois just became the first state to require insurance companies to cover EpiPen injectors for kids
- Health officials recognize vaping as a problem in schools
- Health official who urged abstinence says views have changed
- Health officials investigating Hepatitis A outbreak in North Alabama
- Health officials: Flu continues to be active in Alabama
- Health officials: Hepatitis A outbreak in North Alabama is growing